IDEAS home Printed from https://ideas.repec.org/a/spr/eujhec/v26y2025i7d10.1007_s10198-025-01766-7.html
   My bibliography  Save this article

Preferences for health-related quality of life: do they vary by age? A systematic literature review on the EQ-5D measure

Author

Listed:
  • Alhanouf Alabbad

    (National Pharmacovigilance Center, Saudi Food and Drug Authority)

  • Madeleine Cochrane

    (Health Economics and Health Policy, Population Health Sciences, Bristol Medical School, University of Bristol)

  • Paul Mark Mitchell

    (Health Economics and Health Policy, Population Health Sciences, Bristol Medical School, University of Bristol)

Abstract

Introduction Cost-utility analysis (CUA) is a commonly used method in Health technology assessment (HTA) that utilises generic metrics such as quality-adjusted life years (QALYs). QALY is a measure derived from individuals’ preferences for different health states, with these preferences represented as utility values. However, utility values may differ by age, raising equity concerns in healthcare allocation. Given the globally ageing demographic, understanding the age-utility relationship becomes essential. Objectives This systematic review aimed to explore the impact of age on utility values derived from the EQ-5D, a widely used instrument in CUA that contributes to calculating QALYs by assessing five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Methods Our search used the comprehensive pearl growing approach and database searching. We included studies that analysed the effect of age on EQ-5D utility values in the general population. We excluded qualitative, non-English, and non-EQ-5D instrument studies. Quality was appraised using the Joanna Briggs Institute tool, and a narrative synthesis was used. Results Of the 28 studies reviewed, primarily from Europe and the Americas, the average age of participants ranged from 34.1 and 47.7 years. Around 46% (n = 13) associated older age with lower utility values; 28% (n = 8) with higher utility; and 25% (n = 7) found no consistent relationship between age and utility. Discussion Age was identified as a critical factor affecting EQ-5D-derived utility values, with implications for the equitable distribution of healthcare resources. These findings corroborate previous research on utility measurement across different instruments, highlighting the ethical and policy issues due to age-related utility differences.

Suggested Citation

  • Alhanouf Alabbad & Madeleine Cochrane & Paul Mark Mitchell, 2025. "Preferences for health-related quality of life: do they vary by age? A systematic literature review on the EQ-5D measure," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 26(7), pages 1275-1291, September.
    • Handle: RePEc:spr:eujhec:v:26:y:2025:i:7:d:10.1007_s10198-025-01766-7
    DOI: 10.1007/s10198-025-01766-7
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s10198-025-01766-7
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s10198-025-01766-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to

    for a different version of it.

    References listed on IDEAS

    as
    1. F. E. van Nooten & X. Koolman & W. B. F. Brouwer, 2009. "The influence of subjective life expectancy on health state valuations using a 10 year TTO," Health Economics, John Wiley & Sons, Ltd., vol. 18(5), pages 549-558, May.
    2. Anne Spencer & Ewan Tomeny & Ruben E. Mujica-Mota & Angela Robinson & Judith Covey & Jose Luis Pinto-Prades, 2019. "Do time trade-off values fully capture attitudes that are relevant to health-related choices?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(4), pages 559-568, June.
    3. Emelie Heintz & Andreas Gerber-Grote & Salah Ghabri & Francoise Hamers & Valentina Rupel & Renata Slabe-Erker & Thomas Davidson, 2016. "Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries," PharmacoEconomics, Springer, vol. 34(1), pages 59-76, January.
    4. Dolan, Paul, 2008. "Developing methods that really do value the ‘Q’ in the QALY," Health Economics, Policy and Law, Cambridge University Press, vol. 3(1), pages 69-77, January.
    5. Dolan, Paul & Roberts, Jennifer, 2002. "To what extent can we explain time trade-off values from other information about respondents?," Social Science & Medicine, Elsevier, vol. 54(6), pages 919-929, March.
    6. Mark Sculpher & Amiram Gafni, 2001. "Recognizing diversity in public preferences: The use of preference sub‐groups in cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 10(4), pages 317-324, June.
    7. Robinson, Angela & Dolan, Paul & Williams, Alan, 1997. "Valuing health status using VAS and TTO: What lies behind the numbers?," Social Science & Medicine, Elsevier, vol. 45(8), pages 1289-1297, October.
    8. Michał Jakubczyk, 2009. "Impact of Complementarity and Heterogeneity on Health Related Utility of Life," Central European Journal of Economic Modelling and Econometrics, Central European Journal of Economic Modelling and Econometrics, vol. 1(2), pages 139-156, November.
    9. Floortje van Nooten & Werner Brouwer, 2004. "The influence of subjective expectations about length and quality of life on time trade‐off answers," Health Economics, John Wiley & Sons, Ltd., vol. 13(8), pages 819-823, August.
    10. Paul Mark Mitchell & Tracy E. Roberts & Pelham M. Barton & Joanna Coast, 2017. "Applications of the Capability Approach in the Health Field: A Literature Review," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 133(1), pages 345-371, August.
    11. Drummond, Michael F. & Sculpher, Mark J. & Claxton, Karl & Stoddart, Greg L. & Torrance, George W., 2015. "Methods for the Economic Evaluation of Health Care Programmes," OUP Catalogue, Oxford University Press, edition 4, number 9780199665884.
    12. Samer A. Kharroubi & Christopher McCabe, 2008. "Modeling HUI 2 Health State Preference Data Using a Nonparametric Bayesian Method," Medical Decision Making, , vol. 28(6), pages 875-887, November.
    13. Bram Roudijk & A. Rogier T. Donders & Peep F. M. Stalmeier, 2019. "Cultural Values: Can They Explain Differences in Health Utilities between Countries?," Medical Decision Making, , vol. 39(5), pages 605-616, July.
    14. Emelie Heintz & Andreas Gerber-Grote & Salah Ghabri & Francoise F. Hamers & Valentina Prevolnik Rupel & Renata Slabe-Erker & Thomas Davidson, 2016. "Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries," PharmacoEconomics, Springer, vol. 34(1), pages 59-76, January.
    15. Janneke Grutters & Mark Sculpher & Andrew Briggs & Johan Severens & Math Candel & James Stahl & Dirk Ruysscher & Albert Boer & Bram Ramaekers & Manuela Joore, 2013. "Acknowledging Patient Heterogeneity in Economic Evaluation," PharmacoEconomics, Springer, vol. 31(2), pages 111-123, February.
    16. Mark Oppe & Kim Rand-Hendriksen & Koonal Shah & Juan M. Ramos‐Goñi & Nan Luo, 2016. "EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes," PharmacoEconomics, Springer, vol. 34(10), pages 993-1004, October.
    17. Grewal, Ini & Lewis, Jane & Flynn, Terry & Brown, Jackie & Bond, John & Coast, Joanna, 2006. "Developing attributes for a generic quality of life measure for older people: Preferences or capabilities?," Social Science & Medicine, Elsevier, vol. 62(8), pages 1891-1901, April.
    18. Joanna Coast, 2019. "Assessing capability in economic evaluation: a life course approach?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(6), pages 779-784, August.
    19. Sahar Al Shabasy & Fatima Al Sayah & Maggie Abbassi & Samar Farid, 2022. "Determinants of Health Preferences Using Data from the Egyptian EQ-5D-5L Valuation Study," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 15(5), pages 589-598, September.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Alan de Bromhead & Ronan C. Lyons & Johann Ohler, 2025. "Build Better Health: Evidence from Ireland on Housing Quality and Mortality," Trinity Economics Papers tep1525, Trinity College Dublin, Department of Economics.
    2. Alan de Bromhead & Ronan C. Lyons & Johann Ohler, 2025. "Build Better Health: Evidence from Ireland on Housing Quality and Mortality," Trinity Economics Papers tep1525, Trinity College Dublin, Department of Economics.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Floortje Nooten & Jan Busschbach & Michel Agthoven & Job Exel & Werner Brouwer, 2018. "What should we know about the person behind a TTO?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(9), pages 1207-1211, December.
    2. Sahar Al Shabasy & Fatima Al Sayah & Maggie Abbassi & Samar Farid, 2022. "Determinants of Health Preferences Using Data from the Egyptian EQ-5D-5L Valuation Study," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 15(5), pages 589-598, September.
    3. Kasper M. Johannesen & Karl Claxton & Mark J. Sculpher & Allan J. Wailoo, 2018. "How to design the cost‐effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework," Health Economics, John Wiley & Sons, Ltd., vol. 27(2), pages 41-54, February.
    4. Arthur Attema & Werner Brouwer, 2012. "The way that you do it? An elaborate test of procedural invariance of TTO, using a choice-based design," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(4), pages 491-500, August.
    5. F. E. van Nooten & X. Koolman & W. B. F. Brouwer, 2009. "The influence of subjective life expectancy on health state valuations using a 10 year TTO," Health Economics, John Wiley & Sons, Ltd., vol. 18(5), pages 549-558, May.
    6. Katharine S. Gries & Dean A. Regier & Scott D. Ramsey & Donald L. Patrick, 2017. "Utility Estimates of Disease-Specific Health States in Prostate Cancer from Three Different Perspectives," Applied Health Economics and Health Policy, Springer, vol. 15(3), pages 375-384, June.
    7. Stefan A. Lipman & Brigitte A. B. Essers & Aureliano P. Finch & Ayesha Sajjad & Peep F. M. Stalmeier & Bram Roudijk, 2022. "In a Child’s Shoes: Composite Time Trade-Off Valuations for EQ-5D-Y-3L with Different Proxy Perspectives," PharmacoEconomics, Springer, vol. 40(2), pages 181-192, December.
    8. Patricia Cubi-Molla & Koonal Shah & Kristina Burström, 2018. "Experience-Based Values: A Framework for Classifying Different Types of Experience in Health Valuation Research," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 11(3), pages 253-270, June.
    9. Stefan A. Lipman & Werner B.F. Brouwer & Arthur E. Attema, 2019. "QALYs without bias? Nonparametric correction of time trade‐off and standard gamble weights based on prospect theory," Health Economics, John Wiley & Sons, Ltd., vol. 28(7), pages 843-854, July.
    10. Paul Mark Mitchell & Samantha Husbands & Sarah Byford & Philip Kinghorn & Cara Bailey & Tim J. Peters & Joanna Coast, 2021. "Challenges in developing capability measures for children and young people for use in the economic evaluation of health and care interventions," Health Economics, John Wiley & Sons, Ltd., vol. 30(9), pages 1990-2003, September.
    11. Anne Spencer & Ewan Tomeny & Ruben E. Mujica-Mota & Angela Robinson & Judith Covey & Jose Luis Pinto-Prades, 2019. "Do time trade-off values fully capture attitudes that are relevant to health-related choices?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(4), pages 559-568, June.
    12. Qi Cao & Erik Buskens & Hans L. Hillege & Tiny Jaarsma & Maarten Postma & Douwe Postmus, 2019. "Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 475-482, April.
    13. Coast, Joanna, 2018. "A history that goes hand in hand: Reflections on the development of health economics and the role played by Social Science & Medicine, 1967–2017," Social Science & Medicine, Elsevier, vol. 196(C), pages 227-232.
    14. Stefan A. Lipman & Werner B. F. Brouwer & Arthur E. Attema, 2020. "What is it going to be, TTO or SG? A direct test of the validity of health state valuation," Health Economics, John Wiley & Sons, Ltd., vol. 29(11), pages 1475-1481, November.
    15. Agata Łaszewska & Ayesha Sajjad & Jan Busschbach & Judit Simon & Leona Hakkaart-van Roijen, 2022. "Conceptual Framework for Optimised Proxy Value Set Selection Through Supra-National Value Set Development for the EQ-5D Instruments," PharmacoEconomics, Springer, vol. 40(12), pages 1221-1234, December.
    16. Mathias Kifmann & Luigi Siciliani, 2017. "Average‐Cost Pricing and Dynamic Selection Incentives in the Hospital Sector," Health Economics, John Wiley & Sons, Ltd., vol. 26(12), pages 1566-1582, December.
    17. Arthur E. Attema & Han Bleichrodt & Olivier l’Haridon & Stefan A. Lipman, 2020. "A comparison of individual and collective decision making for standard gamble and time trade-off," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(3), pages 465-473, April.
    18. Poder, Thomas G. & Ameri, Hosein, 2025. "A new SF-6Dv2 value set based on a hybrid model using SG, cTTO, and DCE data," Social Science & Medicine, Elsevier, vol. 366(C).
    19. Thomas Grochtdreis & Judith Dams & Hans-Helmut König & Alexander Konnopka, 2019. "Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(6), pages 933-944, August.
    20. Fredrick Dermawan Purba & Joke A. M. Hunfeld & Aulia Iskandarsyah & Titi Sahidah Fitriana & Sawitri Supardi Sadarjoen & Juan Manuel Ramos-Goñi & Jan Passchier & Jan J. V. Busschbach, 2017. "The Indonesian EQ-5D-5L Value Set," PharmacoEconomics, Springer, vol. 35(11), pages 1153-1165, November.

    More about this item

    Keywords

    ;
    ;
    ;
    ;

    JEL classification:

    • I1 - Health, Education, and Welfare - - Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:26:y:2025:i:7:d:10.1007_s10198-025-01766-7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.